DSpace
 

Academic Knowledge Archives of Gunma Institutes >
群馬大学(Gunma University) >
30 医学系研究科 >
3005 北関東医学会 >
330501 The Kitakanto medical journal >
Vol.61 (2011) >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10087/6015

Title: Nelarabine resistance of childhood T-cell lymphoblastic leukemia/lymphoma cells
Authors: Kanazawa, Takashi
Shiba, Norio
Aizawa, Akira
Okuno, Haruna
Tamura, Kazushi
Tsukada, Shota
Kumamoto, Tadashi
Yamada, Shiro,
Kobayashi, Ysuko
Arakawa, Hirokazu
Keywords: nelarabine
cytarabine
T-ALL
T-LBL
ENT-1
Issue Date: 1-May-2011
Publisher: 北関東医学会
Citation: The Kitakanto medical journal. 61(2), 119-126, 2011
Abstract: Background: Nelarabine (NEL) is a new purine nucleoside analogue that has recently become available for both adults and children with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL)and T-lymphoblastic lymphoma (T-LBL). We studied the drug resistance profile of eight children with T-ALL/LBL using an in vitro cytotoxic assay including NEL. Furthermore, we tried to establish a NEL resistant T-ALL cell line model to investigate the mechanism of NEL resistance. Results : Four of 8 patients showed a higher 50% lethal concentration (LC,o) than the maximum clinical concentration of NEL. There were no correlations in LC,o values between NEL and other drugs. To study the mechanism of NEL resistance, we originally established a nucleoside an alogue resistant T-ALL Jurkat cell line model (Jurkat+C) induced by incubation in medium containing cytarabine (AraC) at LC,o ofthe control. Jurkat+C showed resistance to NEL and Fludarabine as well as AraC but not Daunorubicin. Next, we studied the role of Equivalent Nucleoside Transporter-1 (ENT-1), a major cellular nucleoside transporter, in the acquired drug resistance in Jurkat+ C. Nitrobenzylmercaptopurine riboside, an ENT-1-specific inhibitor, showed an inhibitory efTect of nucleoside analogues on in vitro toxicity in both Jurkat and Jurkat+C, while no difTerences in ENT-1 mRNA expression levels between Jurk at and Jurkat + C were found. Conclusions: in vitro NEL resistance was seen in half of the tested childhood T-ALL cells. We could establish the NEL resistant T-ALL cell line model by AraC exposure. ENT-1 may partly act as a transporter of NEL, but not play a key role in AraC induced NEL resistance. This cell line model may be usefu1 to provide a mechanism to explain NEL resistance.
URI: http://hdl.handle.net/10087/6015
ISSN: 1343-2826
Appears in Collections:Vol.61 (2011)

Files in This Item:

File Description SizeFormat
61_119.pdf192.73 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2010  Duraspace - Feedback